Ensign Peak Advisors’s Evolus EOLS Stock Holding History

Ensign Peak Advisors’s Portfolio EOLS Stock Details EOLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-6,650	Closed	-$54K	–	1918
2022 Q3	$54K	Buy	+6,650	New	+$70.5K	﹤0.01%	2205

Other funds holding EOLS

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

Ensign Peak Advisors's EOLS Position: Q4 2022 in Review

Ensign Peak Advisors sold out of Evolus (EOLS) in Q4 2022, closing a stake of 6,650 shares — an estimated $54K sold.

Ensign Peak Advisors first reported a position in EOLS in Q3 2022 and held it in 1 quarter. The position peaked at $54K in Q3 2022. 120 funds tracked by Wall St. Rank hold EOLS as of Q4 2022.

Ensign Peak Advisors reported no remaining Evolus position as of Q4 2022 after selling out during the quarter.
Ensign Peak Advisors sold 6,650 Evolus shares in Q4 2022, an estimated $54K.
Ensign Peak Advisors first reported a position in Evolus in Q3 2022 and held it in 1 quarter.
Ensign Peak Advisors's Evolus position peaked at $54K in Q3 2022.
120 funds tracked by Wall St. Rank held Evolus as of Q4 2022.

Based on Ensign Peak Advisors's 13F filing for Q4 2022, filed 13 Feb 2023.